iShares Global Healthcare ETF vs VanEck Biotech ETF: Which ETF Is Better for Profiting With Healthcare in 2026?
VanEck's concentrated biotech portfolio surged 30.8% in one year but endured a 39.9% drawdown. iShares offers steadier global healthcare exposure with a 1.5% dividend yield.
Overview
The iShares Global Healthcare ETF (NYSEMKT:IXJ) offers broad, global exposure and lower historical volatility, while the VanEck Biotech ETF (NASDAQ:BBH) provides a concentrated, high-growth play on specialized biotechnology innovators.
Investors deciding between these two healthcare-focused funds must choose between industry-wide stability and sub-sector volatility. One strategy casts a global net across pharmaceuticals, medical equipment, and services, while the other concentrates exclusively on the 25 largest biotechnology companies listed on U.S. exchanges.
Details
Beta measures price volatility relative to the S&P 500; beta is calculated from monthly returns over the available fund history (up to five years). The 1-yr return represents total return over the trailing 12 months. Dividend yield is the trailing-12-month distribution yield as of the close of trading on July 20.
Source
Originally published at www.fool.com.